EUVIMEDEUVIMED entdecken
Open Access

Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers

Bidhan Bhandari iD, Sahar Emami Naeini, Hannah M Rogers, Abdullah Hassan Alhashim, Jack C Yu, Mohammad Seyyedi, Nancy Young, Ahmed El-Marakby, Évila Lopes Salles, Lei P Wang, Babak Baban

Nicotine and Tobacco Research · 2025

DOI: 10.1093/ntr/ntaf253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Bidhan Bhandari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, USA. Hauptthemen laut MEDLINE: Seizures, Nicotine, Cannabidiol, Glymphatic System. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Dental College of Georgia at Augusta University, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Nicotine pouches are rapidly increasing in popularity, yet their long-term neurological consequences remain poorly understood. Emerging evidence suggests nicotine may influence seizure susceptibility and neuroimmune signaling, while cannabidiol (CBD) has demonstrated neuroprotective and anti-inflammatory effects. This study investigated the time-dependent impact of acute versus chronic oral nicotine exposure on seizure vulnerability, neuroinflammation, and glymphatic function, and evaluated whether inhaled CBD can reverse these pathological changes.

Methods

Mice were exposed to acute or 7-day chronic nicotine pouch prior to kainic acid–induced seizures. Seizure severity was scored using the Racine scale. Neuroinflammatory markers (IL-6, HMGB1), neuronal activation markers (BDNF, c-FOS), and Aquaporin-4 (AQP4) expression were quantified via flow cytometry, immunofluorescence, and western blotting. Glymphatic function was assessed using cisterna magna injection of rhodamine dextran tracers. An ex vivo IL-6 modulation assay evaluated nicotine-induced cytokine production and CBD-mediated suppression, with or without IL-6 receptor blockade.

Results

Acute nicotine transiently reduced seizure severity, whereas chronic exposure significantly exacerbated seizures, elevated IL-6, HMGB1, BDNF, and c-FOS, and markedly downregulated AQP4. CSF tracer studies confirmed impaired glymphatic influx following chronic nicotine exposure. CBD inhalation effectively reversed seizure severity restored AQP4 expression, normalized IL-6 and HMGB1 levels, and reduced c-FOS protein expression. The IL-6R blockade assay showed that nicotine induces IL-6 production in brain-derived immune cells, while CBD suppresses this response upstream of IL-6 signaling.

Conclusions

Chronic nicotine pouch exposure promotes seizure susceptibility through converging neuroimmune and glymphatic disruptions. Inhaled CBD counteracts these effects, supporting its potential as a targeted therapeutic strategy for nicotine-associated neurological risk.

Implications

This study provides the first evidence that chronic nicotine pouch exposure disrupts glymphatic function, amplifies neuroinflammation, and increases seizure susceptibility through an IL-6–centered neuroimmune network. These findings challenge the perception of nicotine pouches as low-risk products and highlight previously unrecognized neurological vulnerabilities associated with long-term use. The ability of inhaled CBD to reverse these pathological effects identifies a promising therapeutic strategy and underscores the need for further investigation into neuroimmune–glymphatic interactions in nicotine-related brain health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeizuresNicotineCannabidiolGlymphatic SystemBrainNeuroprotective AgentsAnimalsMiceBiomarkersMaleAquaporin 4Interleukin-6Mice, Inbred C57BLHMGB1 ProteinBrain-Derived Neurotrophic Factor

Substanzen

NicotineBiomarkersCannabidiolAquaporin 4Interleukin-6HMGB1 ProteinBrain-Derived Neurotrophic FactorNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, USA.
  • Center for Excellence in Research, Scholarship and Innovation (CERSI), Dental College of Georgia, Augusta, Augusta University, Augusta, GA, USA.
  • The Graduate School, Augusta University, Augusta, GA, USA.
  • Georgia Institute of Cannabis Research, Medicinal Cannabis of Georgia LLC, Augusta, GA, USA.
  • Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.
  • Piedmont Ear, Nose, Throat and Related Allergy, Atlanta, GA, USA Medical College of Georgia, Augusta University, Augusta, GA, USA.

ORCID-Profile: Bidhan Bhandari

Förderung

  • Dental College of Georgia at Augusta University
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bhandari, B., Naeini, S. E., Rogers, H. M., Alhashim, A. H., Yu, J. C., Seyyedi, M., Young, N., El-Marakby, A., Salles, É. L., Wang, L. P., & Baban, B. (2025). Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntaf253

Vancouver

Bhandari B, Naeini SE, Rogers HM, Alhashim AH, Yu JC, Seyyedi M, et al. Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntaf253

BibTeX
@article{Bhandari2025,
  author = {Bhandari, Bidhan and Naeini, Sahar Emami and Rogers, Hannah M and Alhashim, Abdullah Hassan and Yu, Jack C and Seyyedi, Mohammad and Young, Nancy and El-Marakby, Ahmed and Salles, Évila Lopes and Wang, Lei P and Baban, Babak},
  title = {Protective Role of CBD Against Nicotine Pouch–Induced Seizure Aggravation and Alterations in Brain Glymphatic Biomarkers},
  journal = {Nicotine and Tobacco Research},
  year = {2025},
  doi = {10.1093/ntr/ntaf253}
}
Kostenlos starten →